Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.500
-0.465-5.19%
Volume:1.37M
Turnover:11.71M
Market Cap:8.23B
PE:-70.83
High:9.265
Open:9.250
Low:8.415
Close:8.965
52wk High:15.750
52wk Low:6.230
Shares:968.00M
HK Float Shares:968.00M
Volume Ratio:0.66
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.120
ROE:-6.43%
ROA:-4.42%
PB:4.12
PE(LYR):-70.83
PS:12.46

Loading ...

Jefferies Adjusts Alphamab Oncology's Price Target to HK$9.60 From HK$7, Keeps at Buy

MT Newswires Live
·
Mar 30

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

HK Pharma Stocks Gained. XuanzhuBio Up 9%; Xtalpi, Lepu Bio And Ascletis Up 6%; Akeso Up 5%; Skb Bio Up 4%.

Tiger Newspress
·
Mar 26

Alphamab Oncology Posts FY Loss RMB113.9 Million

Reuters
·
Mar 25

ALPHAMAB-B Reports Annual Loss of RMB 114 Million, Shifting from Profit Year-on-Year

Stock News
·
Mar 25

Alphamab Oncology FY2025 operating loss widens to RMB114 million; revenue falls 11.54% to RMB566 million

Reuters
·
Mar 25

Alphamab Oncology FY2025 revenue falls to CNY 566 million; annual loss widens to CNY 114 million

Reuters
·
Mar 25

Alphamab Oncology FY Revenue RMB 566.2 Million

THOMSON REUTERS
·
Mar 25

HK Pharma Stocks Gained. Wuxi XDC Up 8%; Wuxi AppTec Up 7%; Transthera And HBM Up 5%; Keymed Bio And Innocare Up 4%; Wuxi Bio And Remegen Up 3%

Tiger Newspress
·
Mar 24

ALPHAMAB-B, CSPC Subsidiary Initiate Phase III Trial of KN026 for Adjuvant HER2-Positive Breast Cancer

Bulletin Express
·
Mar 24

ALPHAMAB-B (09966) Doses First Patient in Phase III Trial for KN026 as Adjuvant Therapy in HER2+ Breast Cancer

Stock News
·
Mar 24

Alphamab Oncology doses first patient in Phase 3 KN026 adjuvant HER2+ breast cancer trial

Reuters
·
Mar 24

Alphamab Oncology Doses First Patient in JSKN016 Study

MT Newswires Live
·
Mar 20

ALPHAMAB Oncology (09966.HK) Initiates Phase III Trial: First Patient Dosed with Bispecific ADC JSKN016 for Triple-Negative Breast Cancer

Bulletin Express
·
Mar 20

Alphamab Oncology doses first patient in Phase III JSKN016-301 trial for triple-negative breast cancer

Reuters
·
Mar 20

BRIEF-Alphamab Oncology Appoints Wang Fei As CFO

Reuters
·
Mar 18

Alphamab Oncology Names Former 3SBio Executive as CFO

MT Newswires Live
·
Mar 18

Alphamab-B (09966) Announces Appointment of Wang Fei as Chief Financial Officer; Capital-Markets Vice President Chai Bo to Step Down

Bulletin Express
·
Mar 18

ALPHAMAB-B Appoints Wang Fei as Chief Financial Officer

Stock News
·
Mar 18

Alphamab Oncology - Appoints Wang Fei as CFO

THOMSON REUTERS
·
Mar 18